A report just published by the Australian Institute of Health and Welfare describes the patterns of dispensing of respiratory medications in Australia through a detailed analyses of Pharmaceutical Benefits Scheme (PBS) data, as well as other sources, to draw inferences about respiratory medication use among patients with asthma and COPD.
Respiratory medication use in Australia 2003-2013: treatment of asthma and COPD provides evidence of "substantial over- and under-use of certain classes of medications for management of asthma and COPD. ...Our findings indicate the potential both for better health outcomes and for cost savings to patients and governments by better targeting of treatment for asthma and COPD."
No comments:
Post a Comment